Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
about
Targeted deletion of Wwox reveals a tumor suppressor functionWWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcomeTumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogasterExpression profiling in primates reveals a rapid evolution of human transcription factorsTumor suppressor and hepatocellular carcinomaRole of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancerFunctional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias.WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.WWOX protein expression in normal human tissues.Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours.WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines.Oncosuppressor proteins of fragile sites are reduced in cervical cancer.Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcomaExpression of WW domain-containing oxidoreductase WWOX in pterygiumChronic hepatitis B in hepatocarcinogenesisThe JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.Alteration of WWOX in human cancer: a clinical view.Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductaseOncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.WWOX gene and gene product: tumor suppression through specific protein interactions.WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications.WWOX, large common fragile site genes, and cancer.MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (BMI-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver Cancer Tissue and Normal Liver Tissue
P2860
Q24681190-9235E02B-8B1D-43CE-9A56-B426B660AE6AQ24815527-A1C3D240-B68C-4DF6-B9B7-52BD2A8B2971Q27321940-082D809E-0640-4332-AEF4-5CC56B9E6490Q28300964-51C5515F-B491-4974-AAD3-815A0F1F4DBEQ28389231-2FDEC30F-190B-47C7-8BB2-821410345B08Q28394917-407E2FFB-6EE5-492B-BC8D-050A0B9D5A37Q28829385-288C84B2-0752-4AF9-AB7F-DD7BB52060CAQ33585044-5D0801B9-3F7E-44D1-8B38-607FB8FBF5D3Q33855801-10B9DFAE-04A6-44AB-91FD-424243ACA8FBQ34083679-58B1026F-FE97-4549-B052-0314516B293BQ34083683-45D9690C-607E-4D7A-921A-279C0D2E5279Q34089523-C65957D4-C060-4E76-9FD3-F3E5EE55294AQ34119564-3B8589E3-1721-40C4-A18C-CADF3A43D4FCQ34120466-B65C0D3C-47C5-4EF4-A47E-4C02525D4EAAQ34309523-7EDD1D62-A707-4E16-A677-92B0FE195140Q34330247-1116D391-B645-4F44-B9B7-E2AF7534617BQ35065555-80D6A08C-5592-49A8-8C23-7952B0290D1CQ35780471-53BE9EE2-7E42-4658-A3A2-819116C8CF0BQ36557635-99F21827-3FC6-49AE-AF1B-CD5EB6BC65B7Q36953585-17A69524-2663-4B2F-92D5-5166DA899B53Q37071040-13B4C55B-4EC3-42A0-AF72-29027C72CD26Q37071059-E1DF6439-486B-41D7-9F40-5F9C3DEBEF96Q37687151-7FDB9FBE-6411-490F-B7CB-10781A7261D9Q37690302-B27E014E-1F73-459A-B61B-03F816EE3D22Q38186582-FCB5564F-E0AF-4F2B-9BCF-397C6A1FAAC5Q38321093-06452CA4-3648-4A13-9389-776E54432E20Q38906745-484A50C9-943A-4280-86A9-A0F51D32B1C3Q39254272-ABC93628-0FA1-46F2-BF2D-5D7A40D3428BQ40368333-1F1B9271-7D74-4B78-8452-21D7A41090DAQ41838085-FCC1E864-CA49-4839-A830-E8F3F7E9BF7DQ55003004-93518821-A685-4C13-8E56-CADE8FD07071Q58702230-EED6825C-5F5E-42EE-BF1D-375C3512106B
P2860
Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Frequent downregulation and lo ...... human hepatocellular carcinoma
@ast
Frequent downregulation and lo ...... human hepatocellular carcinoma
@en
Frequent downregulation and lo ...... human hepatocellular carcinoma
@nl
type
label
Frequent downregulation and lo ...... human hepatocellular carcinoma
@ast
Frequent downregulation and lo ...... human hepatocellular carcinoma
@en
Frequent downregulation and lo ...... human hepatocellular carcinoma
@nl
prefLabel
Frequent downregulation and lo ...... human hepatocellular carcinoma
@ast
Frequent downregulation and lo ...... human hepatocellular carcinoma
@en
Frequent downregulation and lo ...... human hepatocellular carcinoma
@nl
P2093
P2860
P356
P1476
Frequent downregulation and lo ...... human hepatocellular carcinoma
@en
P2093
D B Zimonjic
J Ludes-Meyers
M E Durkin
N C Popescu
P2860
P2888
P356
10.1038/SJ.BJC.6602023
P407
P577
2004-08-16T00:00:00Z
P5875
P6179
1012435114